Chest Radiography: Clinical Trials

38 trials of Chest Radiography, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 recruiting, 7 completed, 5 active not recruiting, 5 not yet recruiting. 20 Phase 2, 9 Phase 1, 5 Not applicable, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 220Recruiting 12, Active not recruiting 3, Not yet recruiting 3, Terminated 1, Withdrawn 1
Phase 19Recruiting 6, Active not recruiting 2, Not yet recruiting 1
Not applicable5Completed 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 35Recruiting 3, Completed 2

Follow Chest Radiography: new trials by email Literature Review of Chest Radiography trials Research Report on Chest Radiography

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)2442027-01-152026-10-20
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia
Phase 1RecruitingFred Hutchinson Cancer Center92026-10-152026-09-17
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingSWOG Cancer Research Network902026-10-142026-10-13
Nirogacestat in Patients With Kaposi Sarcoma
Biospecimen Collection, Chest Radiography, Computed Tomography - AIDS-Related Kaposi Sarcoma, Skin Kaposi Sarcoma
Phase 2RecruitingAIDS Malignancy Consortium282026-10-132026-10-20
Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
Archive Sample Retrieval, Biospecimen Collection, Chest Radiography - Glioblastoma, IDH-Wildtype
Phase 2RecruitingMayo Clinic602026-08-282026-10-26
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Bendamustine, Pralatrexate, Bone Marrow Aspiration - Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center502026-04-272026-05-11
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Autologous Anti-CD83 CAR T-cells, Biospecimen Collection, Chest Radiography - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1RecruitingRoswell Park Cancer Institute262026-02-022026-10-27
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Biospecimen Collection, Brachytherapy, Carboplatin - Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3RecruitingNational Cancer Institute (NCI)3362025-11-052026-10-28
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Acute Undifferentiated Leukemia
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center362025-09-232026-05-15
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Anti-GARP Chimeric Antigen Receptor-T Cells, Biospecimen Collection, Chest Radiography - Recurrent Malignant Glioma, Recurrent WHO Grade 3 Glioma
Phase 1RecruitingOhio State University Comprehensive Cancer Center302025-05-212026-05-08
Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan - Recurrent Multiple Myeloma
Phase 1 / Phase 2RecruitingMayo Clinic372025-03-182026-06-25
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
Biopsy, Chest Computed Tomography, Chest Radiography - Adult Pleomorphic Rhabdomyosarcoma, AJCC Grade 2 Sarcoma
Not applicableNot yet recruitingECOG-ACRIN Cancer Research Group15822025-01-282024-07-30
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Biospecimen Collection, Bone Scan, Cabazitaxel - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 3RecruitingSWOG Cancer Research Network5282024-11-272026-01-22
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
Cryosurgery, Robotic Bronchoscopy, Bronchoscopy with Biopsy - Stage I Lung Cancer, Stage II Lung Cancer
Not applicableActive not recruitingVanderbilt-Ingram Cancer Center132024-09-272026-08-18
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Biopsy Procedure, Biospecimen Collection, Chest Radiography - Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)502024-06-252026-10-14
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Best Practice - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2RecruitingNational Cancer Institute (NCI)20002024-06-182026-10-27
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Biospecimen Collection, Carboplatin, Chest Radiography - Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2WithdrawnECOG-ACRIN Cancer Research Group2024-04-122024-07-25

Showing 20 of 38. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (5)  ·  Multiple Myeloma (3)  ·  Burkitt Lymphoma (2)  ·  Dyspnea (2)  ·  Leukemia, Biphenotypic, Acute (2)  ·  Lung Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Myelodysplastic Syndromes (2)  ·  Prostatic Neoplasms (2)  ·  Sarcoma (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Brenner Tumor (1)  ·  COVID-19 (1)  ·  Carcinoma (1)

Sponsors

National Cancer Institute (NCI) (6)  ·  Mayo Clinic (5)  ·  Fred Hutchinson Cancer Center (3)  ·  SWOG Cancer Research Network (3)  ·  Children's Oncology Group (2)  ·  ECOG-ACRIN Cancer Research Group (2)  ·  AIDS Malignancy Consortium (1)  ·  Centre Oscar Lambret (1)  ·  City of Hope Medical Center (1)  ·  Fundacion Clinica Valle del Lili (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)  ·  Joal Beane (1)  ·  M.D. Anderson Cancer Center (1)  ·  NRG Oncology (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

United States (26)  ·  Canada (4)  ·  Puerto Rico (4)  ·  Australia (2)  ·  France (2)  ·  New Zealand (2)  ·  Colombia (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ibrahim Aldoss (2)  ·  Shaji K. Kumar, MD (2)  ·  Brittani K Seynnaeve (1)  ·  Chelsea Peterson, DO (1)  ·  Christina L Roland, MD (1)  ·  Christine D. Berg, MD (1)  ·  Denise R. Aberle, MD (1)  ·  Elizabeth A Mullen (1)  ·  Elizabeth Hopp (1)  ·  Enrico Lupia, MD, PhD (1)  ·  Evanthia Galanis, MD (1)  ·  Fabien Maldonado, MD (1)  ·  Francesco Mazziotta, MD, PhD (1)  ·  German Peces-Barba, MD (1)

Results publications

PMID 17573503, PMID 18024436, PMID 19711141, PMID 19796970, PMID 21119104, PMID 21248232, PMID 21714641, PMID 22627615, PMID 23697514, PMID 24004119, PMID 25199624, PMID 25364884, PMID 25372087, PMID 25635704, PMID 25746779, PMID 25928649, PMID 27006427, PMID 27009070, PMID 27811504, PMID 28069970, PMID 29211618, PMID 30011285, PMID 30821827, PMID 31449468, PMID 34422349, PMID 36902217, PMID 37489991, PMID 37526548, PMID 39287522, PMID 39436294, PMID 39964263, PMID 40059443, PMID 40873341, PMID 42070324, PMID 42574969, PMID 42580153

NIH funding

U10CA180888 (4), U10CA180868 (3), U10CA180886 (3), N1CN25476A-85-0-1 (1), P01CA018029 (1), P30CA033572 (1), P30CA068485 (1), P50CA136393 (1), P50CA186781 (1), R01CA136547 (1), R01CA200507 (1), U01CA079778 (1), U01CA080098 (1), U10CA098543 (1), U10CA180820 (1)